Name | Oxford Nanopore Technologies |
---|---|
Epic | ONT |
Isin | GB00BP6S8Z30 |
Index | UK250 UK350 |
Industry | Pharmaceuticals & Biotechnology |
Latest share price | 130.20p | Net gearing | n/a |
---|---|---|---|
Market capitalisation | £1,242.25 | Debt ratio | n/a |
Shares in issue | 862.82 | Debt-to-equity ratio | n/a |
P/E ratio | n/a | Assets / equity ratio | n/a |
Total dividends per share | n/a | Price to book value | n/a |
Dividend yield | n/a | ROCE | -25.25 |
Dividend cover | n/a | EPS growth | n/a |
Earning per share | -19 | 52-week high / low | 86.55p / 208.20p |
Type | Ex-date | Pay-date | Net-dividend |
---|---|---|---|
No dividends declared |
Company name | Oxford Nanopore Technologies |
---|---|
Address | Gosling Building, Edmund Halley Road, Oxford Science Park, Oxford, United Kingdom, OX4 4DQ |
Telephone | +44 (0)845 034 7900 |
Website | https://nanoporetech.com/investors-update |
Director | Position |
---|---|
Dr Gurdial (Gordon) Sanghera | CEO |
Mr Nick Keher | CFO |
Dr Guy Harmelin | Non-Executive Director |
Mr Sarah Fortune | Non-Executive Director |
Mr Adrian Nevil Hennah | Non-Executive Director |
Mr Heather Preston | Non-Executive Director |
Mr John O'Higgins | Non-Executive Director |
Ms Kate Priestman | Non-Executive Director |
Mr Duncan Tatton-Brown | Non-Executive Chairman |
Mrs Wendy Becker | Senior Independent Director |
Assets £ (m) | 2023 | 2022 | 2021 |
---|---|---|---|
Reporting date | 31/12/23 | 31/12/22 | 31/12/21 |
Intangible asssets and goodwill | 32.91 | 30.04 | 23 |
Investments and other non-current assets | 0.74 | 0.83 | 0.26 |
Total non-current assets | 329.88 | 185.89 | 91.26 |
Inventory / work in progress | 101.55 | 87.7 | 63.07 |
Trade and other receivables | 61.47 | 62.9 | 54.8 |
Cash and equivalents | 220.54 | 356.78 | 487.84 |
Other current assets and asset held for resale | 63.62 | 130.62 | 144.9 |
Total of all assets | 777.06 | 823.89 | 841.87 |
Liabilities £ (m) | 2023 | 2022 | 2021 |
---|---|---|---|
Short term liabilities | 89.2 | 91.54 | 105.04 |
Long term liabilities | 44.01 | 38.8 | 32.85 |
Other liabilites / pension etc | n/a | n/a | n/a |
Total of all liabilities | 133.21 | 130.33 | 137.89 |
Net assets £ (m) | 2023 | 2022 | 2021 |
---|---|---|---|
Net assets | 643.85 | 693.56 | 703.98 |
Equity £ (m) | 2023 | 2022 | 2021 |
---|---|---|---|
Share capital | 0.09 | 0.08 | 0.08 |
Minority interests | n/a | n/a | n/a |
Retained earnings | -257.71 | -105.99 | -15.9 |
Share premium account | 698.55 | 627.56 | 623.76 |
Total equity | 643.85 | 693.56 | 703.98 |
Income £ (m) | 2023 | 2022 | 2021 |
---|---|---|---|
Turnover | n/a | n/a | n/a |
Operating profit | -168.61 | -98.48 | -164.53 |
Pre-tax profit | -149.77 | -83.41 | -166 |